4basebio signs strategic collaboration, marketing agreement with Genezen on synthetic DNA for viral vectorsPUBT·8 hours ago
Valerio Therapeutics signs deal to buy Etherna Immunotherapies for €30 million enterprise valuePUBT·2 days ago, 01:00 AM
Charles River and MVC to develop enterovirus vaccinePharmaceutical Business Review·Aug 21 at 04:05 AMCRL+0.21%
Aspire Biopharma Updates Public Warrant Exercise TermsTip Ranks·Jul 20 at 04:48 PMASBP+2.53%ASBPW0.00%
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-K: FY2025 Revenue: USD 6.202 KEarnings Watch·Apr 24 at 06:11 AMASBPW0.00%
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 1.941 KEarnings Watch·Nov 14, 2025 at 07:24 AMASBPW0.00%
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.41Earnings Watch·Aug 13, 2025 at 04:04 PMASBPW0.00%
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.42Earnings Watch·May 14, 2025 at 03:47 PMASBPW0.00%
